Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 0 | 0 | 0 | 0 | 46 |
| Gross Profit | 0 | N/A | N/A | N/A | 45 |
| Operating Expenses | 960 | 1,051 | 1,281 | 1,537 | 2,380 |
| Operating Income | -960 | -1,051 | -1,281 | -1,537 | -2,334 |
| Interest Expense | 160 | 0 | 0 | 0 | 50 |
| Other Income | 30 | 75 | 38 | -22 | -146 |
| Pre-tax Income | -1,090 | -976 | -1,243 | -1,559 | -2,530 |
| Income Tax | 0 | N/A | N/A | N/A | -210 |
| Net Income Continuous | -1,072 | -976 | -1,243 | -1,559 | -2,513 |
| Net Income Discontinuous | 0 | N/A | N/A | 1,874 | 0 |
| Net Income | $-1,072 | $-976 | $-1,243 | $315 | $-2,513 |
| EPS Basic Total Ops | -1.00 | -0.89 | -1.10 | 0.10 | -2.00 |
| EPS Basic Continuous Ops | -0.78 | -0.89 | -1.10 | -1.30 | -1.88 |
| EPS Basic Discontinuous Ops | -0.03 | N/A | N/A | 1.40 | N/A |
| EPS Diluted Total Ops | -1.00 | -0.89 | -1.10 | 0.10 | -2.00 |
| EPS Diluted Continuous Ops | -0.78 | -0.89 | -1.10 | -1.30 | -1.88 |
| EPS Diluted Discontinuous Ops | -0.03 | N/A | N/A | 1.40 | N/A |
| EBITDA(a) | $-958 | $-1,009 | $-1,232 | $-1,470 | $-2,234 |